Physician
Ohio Valley Physicians INC
Ohio Valley Physicians INC was paid $4.19M by Medicaid between Oct 2019 and Dec 2024, across 22 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 70% of everything it billed.
33Billing provider infoOHIO VALLEY PHYSICIANS INC
WILLIAMSON, WV 25661
WILLIAMSON, WV 25661
33aNPI1811470503assigned 09/10/2018
33bProvider typeFamily Medicine Physician
28Total paid$4.19M
24GClaims102,849
24DCodes billed22
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in West Virginia
Rank by total paid#9 of 202
Median peer was paid$172K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 394 | $6K | |
| 2020 | 12,931 | $349K | |
| 2021 | 25,451 | $1.18M | |
| 2022 | 26,434 | $1.06M | |
| 2023 | 21,350 | $842K | |
| 2024incomplete | 16,289 | $750K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 70% | 29,130 | 13,325 | $2.95M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.3% | 36,107 | 16,805 | $390K |
| 82075 | 5.1% | 13,360 | 6,197 | $216K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 3.9% | 1,120 | 825 | $163K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.7% | 3,268 | 1,520 | $155K |
| 81025 | 2.5% | 13,871 | 6,695 | $103K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.8% | 691 | 508 | $77K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.2% | 1,680 | 1,503 | $50K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 337 | 284 | $29K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | <1% | 524 | 304 | $28K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,487 | 1,205 | $14K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 209 | 144 | $5K |
10 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 560 | $5K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 77 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 267 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 19 | $915.58 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 13 | $599.30 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $432.48 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 50 | $157.84 |
| 36415 | Collection of venous blood by venipuncture | <1% | 37 | $16.90 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 15 | $11.62 |
| 99000 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLANDERS, TARA (DIRECTOR OF CREDENTIALING)
| Provider | Location | Paid |
|---|---|---|
| Ohio Valley Physicians INC | Huntington, WV | $43.04M |
| Ohio Valley Physicians, INC | Pikeville, KY | $2.47M |
| Ovp Health Care, INC. | Florence, SC | $139K |
| Ohio Valley Physicians INC | Athens, OH | $11K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.